EC signs deal with pharma company to combat diphtheria

The latest update reveals that EC has signed a deal with a pharma company to combat diphtheria. This partnership aims to develop new treatments and vaccines to address the growing threat of the disease. The collaboration is a significant step towards improving public health and saving lives.

Source link